Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat
- 1 November 1989
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 3 (6) , 865-872
- https://doi.org/10.1007/bf01869574
Abstract
Angiotensin-converting enzyme (ACE) inhibitors decrease blood pressure by reducing systemic vascular resistance. That the peripheral vasodilating properties of ACE inhibitors might not be homogeneously distributed in all vascular beds and might differ from one drug to another has been investigated in the normotensive rat by the pulsed Doppler technique using the active components of four different ACE inhibitors: captopril, enalapril, perindopril, and ramipril. Systemic (cardiac output and blood pressure) and regional (kidney, mesentery, hindquarter) hemodynamic responses to saline or to cumulative bolus injections (0.01–1 mg/kg) of captopril, enalaprilat, perindoprilat, or ramiprilat were continuously monitored. The effects of successive bolus injections (0.3–300 ng/kg) of angiotensinII were also investigated. The four ACE inhibitors produced an almost complete blockade of plasma angiotensin-II converting-enzyme activity (83%, 100%, 100%, and 100%, respectively), induced dose-dependent decreases in mean blood pressure, did not significantly affect cardiac output, and reduced total peripheral and mesenteric vascular resistances to the same extent. Hindlimb vascular resistance was identically decreased, but to a lower extent than total peripheral resistance by enalaprilat, perindoprilat, and ramiprilat, whereas it was increased by captopril at low doses only. Renal resistance was markedly decreased by the four drugs, and éspecially by captopril. The decreasing rank order for ACE-inhibitor-induced vasodilation is exactly the same (renal>total peripheral=mesenteric >hindlimb vascular resistances) as that of angiotensin-II-induced regional vasoconstriction, indicating that the vasodilator properties of ACE inhibitors are mainly due to angiotensin-II vasomotor tone suppression. None of the investigated compounds significantly affected mesenteric and hindlimb blood flows, except captopril, which lowered the latter significantly. Finally, the four drugs increased renal blood flow markedly. Thus, the four drugs exhibited different regional vasodilating patterns, those of enalaprilat, perindoprilat, and ramiprilat being almost similar, while that of captopril was different.This publication has 21 references indexed in Scilit:
- Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive ratThe American Journal of Cardiology, 1987
- Ramipril: Review of pharmacologyThe American Journal of Cardiology, 1987
- Antihypertensive Action of the Converting Enzyme Inhibitor Perindopril (S9490-3) in Spontaneously Hypertensive Rats: Comparison with Enalapril (MK421) and Ramipril (HOE498)Journal of Cardiovascular Pharmacology, 1986
- Effects of Acute and Chronic Angiotensin-Converting Enzyme Inhibition on Large Arteries in Human HypertensionJournal of Cardiovascular Pharmacology, 1985
- Inhibition of Angiotensin I-Converting Enzyme with S 9490Journal of Cardiovascular Pharmacology, 1984
- Influence of captopril and enalapril on regional vascular alpha-adrenergic receptor reactivity in SHR.Hypertension, 1984
- Action of Vasodilating Drugs on Small and Large Arteries of Hypertensive PatientsJournal of Cardiovascular Pharmacology, 1983
- Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.Hypertension, 1983
- Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids.Hypertension, 1983
- Effects of long-term blockade of angiotensin converting enzyme with captopril (SQ14,225) on hemodynamics and circulating blood volume in SHR.Hypertension, 1980